# Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

> **NCT06188455** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 37 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Fluzoparib Capsules
- **DRUG:** Apatinib Mesylate Tablets

## Key facts

- **NCT ID:** NCT06188455
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188455, "Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06188455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*